NEW DELHI: Drug major Cipla on Friday posted 73% rise in consolidated net profit at Rs 412 crore for the quarter ended March on the back of robust sales across markets.
The Mumbai-based firm had reported a net profit of Rs 238 crore in January-March 2020. Revenue from operations rose to Rs 4,606 crore as compared with Rs 4,376 crore in the same period of FY20, Cipla said in a regulatory filing.
Cipla reported a consolidated net profit of Rs 2,389 crore in FY21 as against Rs 1,500 crore in FY20. Revenue from operations in FY21 rose to Rs 19,160 crore as against Rs 17,132 crore in FY20. The drug maker said its domestic prescription business grew 6% while the overall business in South Africa rose 10% on a year-on-year basis. Similarly, the US business reported $138 million in revenue